ClearPoint Neuro, Inc.
CLPT
$10.33
-$0.20-1.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.79M | -18.91M | -18.15M | -17.98M | -20.63M |
| Total Depreciation and Amortization | 1.76M | 1.90M | 1.86M | 1.78M | 1.66M |
| Total Amortization of Deferred Charges | 36.00K | 51.00K | 66.00K | 58.00K | 58.00K |
| Total Other Non-Cash Items | 7.38M | 6.61M | 6.60M | 6.72M | 7.16M |
| Change in Net Operating Assets | 335.00K | 1.40M | 754.00K | -57.00K | -132.00K |
| Cash from Operations | -11.28M | -8.95M | -8.88M | -9.47M | -11.88M |
| Capital Expenditure | -458.00K | -275.00K | -33.00K | -256.00K | -579.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -167.00K | -167.00K | 9.67M |
| Cash from Investing | -458.00K | -275.00K | -200.00K | -423.00K | 9.09M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -10.00M | -10.00M | -10.00M | -- | -- |
| Issuance of Common Stock | 430.00K | 16.61M | 16.68M | 16.68M | 16.71M |
| Repurchase of Common Stock | -1.58M | -424.00K | -377.00K | -407.00K | -356.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -78.00K | -- | -- | -- | -- |
| Cash from Financing | -11.23M | 6.19M | 6.31M | 16.28M | 16.35M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.97M | -3.04M | -2.77M | 6.38M | 13.56M |